M Prete
Overview
Explore the profile of M Prete including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fassio A, Porciello G, Carioli G, Palumbo E, Vitale S, Luongo A, et al.
Reumatismo
. 2024 Mar;
76(1).
PMID: 38523582
Objective: To report cross-sectionally serum levels of 25-hydroxyvitamin D [25(OH)D] in women living in Italy within 12 months from breast cancer (BC) diagnosis. Methods: Baseline data were obtained from 394...
2.
Dominguez Conde C, Xu C, Jarvis L, Rainbow D, Wells S, Gomes T, et al.
Science
. 2022 May;
376(6594):eabl5197.
PMID: 35549406
Despite their crucial role in health and disease, our knowledge of immune cells within human tissues remains limited. We surveyed the immune compartment of 16 tissues from 12 adult donors...
3.
Prete M, Favoino E, Giacomelli R, Afeltra A, Cantatore F, Bruno C, et al.
Clin Exp Med
. 2019 Nov;
20(1):31-37.
PMID: 31679095
Raynaud's phenomenon (RP) is a clinical disorder characterized by recurrent, reversible episodes of digital vasospasm. RP can be classified as primary (pRP) or secondary, depending on whether it occurs as...
4.
Prete M, Leone P, Frassanito M, Desantis V, Marasco C, Cicco S, et al.
Lupus
. 2018 Sep;
27(12):1926-1935.
PMID: 30180771
Belimumab, a specific inhibitor of the soluble B lymphocyte stimulator (BlyS), is the first biological drug approved by the United States Food and Drug Administration for the treatment of patients...
5.
Favoino E, Favia I, Vettori S, Vicenti C, Prete M, Valentini G, et al.
Clin Exp Immunol
. 2015 Apr;
181(1):100-9.
PMID: 25847615
Human leucocyte antigen (HLA)-G has a tolerogenic function and could play a role in the pathogenesis of immune-mediated diseases, including systemic sclerosis (SSc). The aim of this study was to...
6.
Prete M, Fatone M, Vacca A, Racanelli V, Perosa F
Clin Exp Rheumatol
. 2013 Dec;
32(2):267-74.
PMID: 24351505
Severe pulmonary arterial hypertension (PAH) is rarely observed as the initial manifestation of systemic lupus erythematosus (SLE), and the diagnosis is often delayed. Here we present the case of a...
7.
Perosa F, Prete M, Racanelli V, Dammacco F
J Intern Med
. 2010 Mar;
267(3):260-77.
PMID: 20201920
The B lymphocyte-associated antigen CD20 is becoming an important immunotherapy target for autoimmune diseases, although its biological function has not been defined. Besides rheumatoid arthritis, growing experience with B cell-depleting...
8.
Fabris C, Coscia A, Bertino E, Prete M, Occhi L, Giuliani F, et al.
Early Hum Dev
. 2009 Oct;
85(10 Suppl):S47-8.
PMID: 19833463
Counselling is a professional intervention based on skills to communicate and to build relationships. The project "Not alone", related to counselling at our Neonatal Intensive Care Unit, is aimed to...
9.
Prete M, Perosa F, Favoino E, Dammacco F
Clin Exp Med
. 2005 Dec;
5(4):141-60.
PMID: 16362794
Most autoimmune diseases (ADs) are still associated with high morbidity and mortality despite the use of a wide range of drugs that can delay their progression, control their symptoms, but...
10.
Perosa F, Prete M, Luccarelli G, Favoino B, Dammacco F
Eur J Immunogenet
. 2002 Oct;
29(5):409-12.
PMID: 12358850
No monoclonal antibodies (mAbs) are presently available to measure the total amount of beta2-microglobulin-free HLA class I heavy chain (FHC) in sera. The available ELISA-based double determinant immunoassay (DDIA), established...